Detalhe da pesquisa
1.
Impact of timing and format of patient decision aids for breast cancer patients on their involvement in and preparedness for decision making - the IMPACTT randomised controlled trial protocol.
BMC Cancer
; 24(1): 336, 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38475758
2.
Decision aids for people facing health treatment or screening decisions.
Cochrane Database Syst Rev
; 1: CD001431, 2024 01 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38284415
3.
Communicating without a Shared Language: A Qualitative Study of Language Barriers in Language-Discordant Cancer Communication.
J Health Commun
; 29(3): 187-199, 2024 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38294170
4.
Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer.
Future Oncol
; 19(35): 2361-2367, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37965794
5.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31562800
6.
Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer.
Cell Commun Signal
; 20(1): 176, 2022 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36352420
7.
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.
Gynecol Oncol
; 164(2): 278-287, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34930617
8.
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.
Gynecol Oncol
; 164(2): 245-253, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34906376
9.
When life gives you no choice: Context of decision-making when offered an oncology clinical trial.
Scand J Caring Sci
; 36(1): 81-89, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33606286
10.
Patients' experiences of the decision-making process for clinical trial participation.
Nurs Health Sci
; 24(1): 65-72, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35212102
11.
Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trial.
Gynecol Oncol
; 162(2): 375-381, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34112513
12.
The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness.
Acta Oncol
; 60(4): 434-443, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33651647
13.
Treosulfan in platinum-resistant ovarian cancer.
Int J Gynecol Cancer
; 31(7): 1045-1051, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34006568
14.
Association of patient-reported outcomes and ovarian cancer recurrence.
Int J Gynecol Cancer
; 31(9): 1248-1259, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34489355
15.
Blood natural killer cells during treatment in recurrent ovarian cancer.
Acta Oncol
; 59(11): 1365-1373, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32692270
16.
Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer - a pilot randomized controlled trial.
Acta Oncol
; 59(4): 444-452, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32000559
17.
Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma.
Acta Oncol
; 59(6): 652-659, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31931651
18.
Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol.
Int J Gynecol Cancer
; 30(9): 1444-1449, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32586892
19.
Delta tocotrienol in recurrent ovarian cancer. A phase II trial.
Pharmacol Res
; 141: 392-396, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30639384
20.
The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
Int J Gynecol Cancer
; 29(1): 166-173, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30640700